Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the Alzheimer's disease group:
- People who have been diagnosed with "probable Alzheimer's disease dementia" based on established international diagnostic guidelines
- People whose memory and thinking test scores fall within a specific range, indicating mild to severe cognitive decline (confirm with trial site for exact score requirements)
- People whose brain MRI scan shows shrinkage in the memory-related areas of the brain (the temporal lobes and hippocampus on both sides)
- People aged 50 years or older
For the healthy comparison group:
- Healthy people whose age is similar to those in the Alzheimer's disease group
- People with normal memory and thinking abilities and no significant difficulty with everyday activities
- People who have no close family members (parents, siblings, or children) diagnosed with dementia
- People whose brain MRI scan and neurological check-up show no abnormal findings
Who may not be able to join:
- People whose memory or thinking problems are caused by a condition other than Alzheimer's disease
- People with a history of substance or alcohol misuse
- People with a condition involving progressive loss of language ability (progressive primary aphasia)
- People who have previously had a traumatic brain injury
- People who also have depression, schizophrenia, or serious heart, liver, kidney, or blood-related health conditions
- People who have difficulty with consciousness or are unable to cooperate with the study procedures
- People with other conditions the trial site considers unsuitable for participation (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613705790560
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between miR-342-5p/AnkG Pathway and Synaptic Proteins
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.